These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26559835)

  • 1. HIV-1 Virion Production from Single Inducible Proviruses following T-Cell Activation Ex Vivo.
    Bui JK; Mellors JW; Cillo AR
    J Virol; 2016 Feb; 90(3):1673-6. PubMed ID: 26559835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy.
    Cillo AR; Sobolewski MD; Bosch RJ; Fyne E; Piatak M; Coffin JM; Mellors JW
    Proc Natl Acad Sci U S A; 2014 May; 111(19):7078-83. PubMed ID: 24706775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells.
    Bui JK; Halvas EK; Fyne E; Sobolewski MD; Koontz D; Shao W; Luke B; Hong FF; Kearney MF; Mellors JW
    PLoS Pathog; 2017 Feb; 13(2):e1006230. PubMed ID: 28225830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
    Siliciano JD; Siliciano RF
    J Infect Dis; 2021 Feb; 223(12 Suppl 2):13-21. PubMed ID: 33586775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
    Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L
    J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
    Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells.
    Lindqvist B; Svensson Akusjärvi S; Sönnerborg A; Dimitriou M; Svensson JP
    PLoS Pathog; 2020 Jan; 16(1):e1008264. PubMed ID: 31999790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
    Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
    PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses.
    Bruner KM; Wang Z; Simonetti FR; Bender AM; Kwon KJ; Sengupta S; Fray EJ; Beg SA; Antar AAR; Jenike KM; Bertagnolli LN; Capoferri AA; Kufera JT; Timmons A; Nobles C; Gregg J; Wada N; Ho YC; Zhang H; Margolick JB; Blankson JN; Deeks SG; Bushman FD; Siliciano JD; Laird GM; Siliciano RF
    Nature; 2019 Feb; 566(7742):120-125. PubMed ID: 30700913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
    Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
    Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation.
    Li P; Kaiser P; Lampiris HW; Kim P; Yukl SA; Havlir DV; Greene WC; Wong JK
    Nat Med; 2016 Jul; 22(7):807-11. PubMed ID: 27294875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.
    Pinzone MR; O'Doherty U
    Retrovirology; 2018 Feb; 15(1):22. PubMed ID: 29452580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between intact HIV-1 proviruses in circulating CD4
    Lu CL; Pai JA; Nogueira L; Mendoza P; Gruell H; Oliveira TY; Barton J; Lorenzi JCC; Cohen YZ; Cohn LB; Klein F; Caskey M; Nussenzweig MC; Jankovic M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11341-E11348. PubMed ID: 30420517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.
    Descours B; Petitjean G; López-Zaragoza JL; Bruel T; Raffel R; Psomas C; Reynes J; Lacabaratz C; Levy Y; Schwartz O; Lelievre JD; Benkirane M
    Nature; 2017 Mar; 543(7646):564-567. PubMed ID: 28297712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
    Thibault S; Imbeault M; Tardif MR; Tremblay MJ
    Virology; 2009 Jun; 389(1-2):20-5. PubMed ID: 19447460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents.
    Vollbrecht T; Angerstein AO; Menke B; Kumar NM; de Oliveira MF; Richman DD; Guatelli JC
    Retrovirology; 2020 Nov; 17(1):36. PubMed ID: 33228686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved assays to measure and characterize the inducible HIV reservoir.
    Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
    EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.